SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B
http://www.w3.org/2000/01/rdf-schema#comment
"All-trans retinoic acid and protein kinase C alpha/beta1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression."
xsd:string
http://purl.uniprot.org/uniprot/#_962B7C6E55F31DE9D9E7DCE97D1AA772CD0A82D79AA1EE6949E1D66A48A4E758A0FDF4447ABA46666C2B85FE1ECB8DE8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B
http://purl.uniprot.org/uniprot/P20444
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B
http://purl.uniprot.org/uniprot/#_P20444-mappedCitation-33723318
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A6037057D586100D753A307C8BCF25C301E3C5398F490CB5E102ECA9E8078B4118A1772277C56D6EFBD42ABC1262995B